Life Sciences Investing

Arsenal Capital Partners will acquire Fortrea’s enabling services segment and patient access businesses, according to a news release.

Fortea (Nasdaq: FTRE), a global clinical research organization based in Research Triangle Park, N.C., is divesting its Endpoint Clinical and Fortrea

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Arsenal Acquires Multiple Companies From Fortrea

Linden Capital Partners has announced the acquisition of Alcresta Therapeutics.

Alcresta, founded in 2011 and based in Newton, Mass., develops and commercializes enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.

Linden

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Linden Acquires Alcresta Therapeutics

Vesey Street Capital Partners (VSCP) has announced the completion of a majority recapitalization of Inceptua Group.

Inceptua, founded in 1997 and with its U.S. office in Princeton, N.J., is provider of clinical trial supplies and related services.

VSCP

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Vesey Recaps Inceptua Group

Windjammer Capital has announced it has acquired Bio X Cell (BXC).

BXC, founded in 1997 and based in Lebanon, N.H., is a producer of monoclonal antibodies for use in both in vivo and in vitro pre-clinical research applications.

Windjammer

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Windjammer Acquires Bio X Cell

QHP Capital has announced it has acquired Applied StemCell.

Applied StemCell, founded in 2008 and based in Milpitas, Calif., develops gene editing and stem cell technology platforms designed to help advance broader cell therapy manufacturing.

QHP, based in

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: QHP Acquires Applied StemCell

Gurnet Point Capital and Novo Holdings have completed their acquisition of Paratek Pharmaceuticals in a deal valued at $462 million, according to a news release.

Paratek, founded in 1996 and based in Boston, is a commercial-stage biopharmaceutical company

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Gurnet Point and Novo Holdings Acquire Paratek Pharmaceuticals

Bain Capital Private Equity will acquire Harrington Process Solutions, according to a news release.

Harrington, founded in 1959 and based in Chino, Calif., is a specialty distributor of industrial flow control process solutions. Harrington provides solutions to a wide

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital to Acquire Harrington Process Solutions

Grant Avenue Capital has announced it has participated in a recapitalization of CREO with founding partners of the company.

CREO, founded in 2015 and based in Durham, N.C., is a provider of strategy, merger and acquisition, digital transformation, cybersecurity

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Grant Avenue Invests in CREO

FFL Partners has announced it has completed a growth investment in Johnson County Clin-Trials (JCCT).

JCCT, based in Lenexa, Kan., is a clinical research site platform serving pharmaceutical and biotechnology companies and contract research organizations. Founded in 2005, JCCT

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: FFL Invests in Johnson County Clin-Trials